KYMR vs WRK
Kymera Therapeutics Inc (KYMR) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
WRK (WRK) common stock.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
WRK does not have a complete income-statement cache yet.
KYMR currently screens at market cap $7.39B.
Not investment advice. Open the KYMR and WRK stock pages for the full models.
Not investment advice.